PulseAugur
EN
LIVE 02:27:16
中文(ZH) 纳米递送载体将肺癌药利用度提高30倍

Australian scientists develop nanoparticle drug delivery for lung cancer

Scientists at the University of Adelaide have developed a novel nanoparticle delivery system that significantly enhances the bioavailability of lung cancer drugs. This new carrier precisely targets the lungs, increasing drug effectiveness by up to 30 times while minimizing damage to healthy organs. This advancement holds promise for transforming the treatment of lung cancer and other forms of the disease. AI

IMPACT Potential to significantly improve cancer treatment efficacy and reduce side effects.

RANK_REASON Research paper published in Nature detailing a new scientific discovery. [lever_c_demoted from research: ic=1 ai=0.4]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Nanodelivery carriers increase lung cancer drug bioavailability by 30 times

    据物理学家组织网6月2日报道,澳大利亚阿德莱德大学科学家研制出一种新型纳米颗粒递送载体,能将肺癌药物精准靶向肺部,让药物的生物利用度(即所服用药物的剂量能到达体循环的比例)提高30倍,同时大幅减少对健康器官的干扰与损伤。这项突破有望重塑肺癌乃至多种癌症的治疗面貌。(科技日报)